NCT04891744 2021-05-18
Selinexor in Combination With Thalidomide and Dexamethasone in RRMM
Sichuan University
Phase 1/2 Unknown
Clinical Trials
13 trialsNCT02545907 2021-04-15
CATALYST
University College, London
Phase 1/2 Completed
NCT00966693 2020-11-04
Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT00038246 2018-10-31
Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT01057225 2017-12-12
Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma
Mayo Clinic
Phase 1/2 Completed
NCT00406978 2016-05-10
MPTD
University of Turin, Italy
Phase 1/2 Completed
NCT00971126 2016-05-04
Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)
National Health Research Institutes, Taiwan
Phase 1/2 Terminated
NCT02145715 2015-06-26
MUKsix
University of Leeds
Phase 1/2 Unknown
NCT00096018 2013-10-24
Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
Roswell Park Cancer Institute
Phase 1/2 Completed
NCT00005815 2013-06-19
Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT00277017 2011-09-27
Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma
New Mexico Cancer Research Alliance
Phase 1/2 Completed
NCT00081757 2010-07-02
An Open Protocol for the Compassionate Use of Thalidomide
University of Arkansas
Phase 1/2 Completed
NCT00155272 2005-09-12
Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 1/2 Unknown